FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2002125427> ?p ?o ?g. }

• W2002125427 endingPage "474" @default.
• W2002125427 startingPage "470" @default.
• W2002125427 abstract "Human leukocyte antigen class I (HLA-I) molecules are transmembrane glycoproteins that have been reported to be down-regulated in multiple types of human malignancies, including clear cell renal cell carcinoma (CCRCC). However, only one study has investigated its prognostic value in CCRCC. In the present study, HLA-I protein expression was analyzed in 120 archived, paraffin-embedded CCRCC samples and 10 adjacent normal tissues using immunohistochemistry. The correlation between HLA-I expression and clinicopathological factors was evaluated by the χ(2) test. Patients' overall survival was analyzed by the Kaplan-Meier method. HLA-I down-regulation was observed in 38.3% (46/120) of renal tumor samples, but only in 10% (1/10) of adjacent normal tissues. Statistical analysis showed a significant correlation of HLA-I expression with TNM stage, lymph node metastasis, and Fuhrman grade. Patients with tumors displaying down-regulation of HLA-I showed significantly shorter overall survival (P=0.021, log-rank test). More importantly, multivariate analysis indicated that down-regulation of HLA-I was an independent prognostic factor for CCRCC patients (P=0.033). Overall, our data suggest that HLA-I down-regulation is associated with tumor progression and a poor prognosis in CCRCC patients, and emphasize the importance of HLA-I in natural and therapeutic immune surveillance of patients with CCRCC." @default.
• W2002125427 created "2016-06-24" @default.
• W2002125427 creator A5019354520 @default.
• W2002125427 creator A5029667848 @default.
• W2002125427 creator A5041587003 @default.
• W2002125427 creator A5052090282 @default.
• W2002125427 creator A5075457404 @default.
• W2002125427 creator A5076123883 @default.
• W2002125427 creator A5083903113 @default.
• W2002125427 date "2013-06-01" @default.
• W2002125427 modified "2023-10-08" @default.
• W2002125427 title "Down-regulation of human leukocyte antigen class I (HLA-I) is associated with poor prognosis in patients with clear cell renal cell carcinoma" @default.
• W2002125427 cites W1533392829 @default.
• W2002125427 cites W1572974196 @default.
• W2002125427 cites W1980094840 @default.
• W2002125427 cites W1991396576 @default.
• W2002125427 cites W1994126734 @default.
• W2002125427 cites W1997733825 @default.
• W2002125427 cites W2005431410 @default.
• W2002125427 cites W2005765588 @default.
• W2002125427 cites W2015838495 @default.
• W2002125427 cites W2020124219 @default.
• W2002125427 cites W2022263087 @default.
• W2002125427 cites W2024223018 @default.
• W2002125427 cites W2038032899 @default.
• W2002125427 cites W2038234029 @default.
• W2002125427 cites W2054844932 @default.
• W2002125427 cites W2056454490 @default.
• W2002125427 cites W2059378562 @default.
• W2002125427 cites W2062518236 @default.
• W2002125427 cites W2066057073 @default.
• W2002125427 cites W2066604995 @default.
• W2002125427 cites W2070660250 @default.
• W2002125427 cites W2073673847 @default.
• W2002125427 cites W2080757497 @default.
• W2002125427 cites W2083208194 @default.
• W2002125427 cites W2105818762 @default.
• W2002125427 cites W2131554549 @default.
• W2002125427 cites W2135139265 @default.
• W2002125427 cites W2151163706 @default.
• W2002125427 cites W2155629434 @default.
• W2002125427 cites W2158852351 @default.
• W2002125427 cites W2161934710 @default.
• W2002125427 cites W4232744860 @default.
• W2002125427 doi "https://doi.org/10.1016/j.acthis.2012.11.002" @default.
• W2002125427 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23245688" @default.
• W2002125427 hasPublicationYear "2013" @default.
• W2002125427 type Work @default.
• W2002125427 sameAs 2002125427 @default.
• W2002125427 citedByCount "14" @default.
• W2002125427 countsByYear W20021254272014 @default.
• W2002125427 countsByYear W20021254272015 @default.
• W2002125427 countsByYear W20021254272016 @default.
• W2002125427 countsByYear W20021254272017 @default.
• W2002125427 countsByYear W20021254272020 @default.
• W2002125427 countsByYear W20021254272021 @default.
• W2002125427 countsByYear W20021254272022 @default.
• W2002125427 countsByYear W20021254272023 @default.
• W2002125427 crossrefType "journal-article" @default.
• W2002125427 hasAuthorship W2002125427A5019354520 @default.
• W2002125427 hasAuthorship W2002125427A5029667848 @default.
• W2002125427 hasAuthorship W2002125427A5041587003 @default.
• W2002125427 hasAuthorship W2002125427A5052090282 @default.
• W2002125427 hasAuthorship W2002125427A5075457404 @default.
• W2002125427 hasAuthorship W2002125427A5076123883 @default.
• W2002125427 hasAuthorship W2002125427A5083903113 @default.
• W2002125427 hasConcept C126322002 @default.
• W2002125427 hasConcept C142724271 @default.
• W2002125427 hasConcept C143998085 @default.
• W2002125427 hasConcept C146357865 @default.
• W2002125427 hasConcept C147483822 @default.
• W2002125427 hasConcept C151730666 @default.
• W2002125427 hasConcept C188280979 @default.
• W2002125427 hasConcept C203014093 @default.
• W2002125427 hasConcept C204232928 @default.
• W2002125427 hasConcept C2777472916 @default.
• W2002125427 hasConcept C2781278892 @default.
• W2002125427 hasConcept C502942594 @default.
• W2002125427 hasConcept C71924100 @default.
• W2002125427 hasConcept C86803240 @default.
• W2002125427 hasConcept C8891405 @default.
• W2002125427 hasConceptScore W2002125427C126322002 @default.
• W2002125427 hasConceptScore W2002125427C142724271 @default.
• W2002125427 hasConceptScore W2002125427C143998085 @default.
• W2002125427 hasConceptScore W2002125427C146357865 @default.
• W2002125427 hasConceptScore W2002125427C147483822 @default.
• W2002125427 hasConceptScore W2002125427C151730666 @default.
• W2002125427 hasConceptScore W2002125427C188280979 @default.
• W2002125427 hasConceptScore W2002125427C203014093 @default.
• W2002125427 hasConceptScore W2002125427C204232928 @default.
• W2002125427 hasConceptScore W2002125427C2777472916 @default.
• W2002125427 hasConceptScore W2002125427C2781278892 @default.
• W2002125427 hasConceptScore W2002125427C502942594 @default.
• W2002125427 hasConceptScore W2002125427C71924100 @default.
• W2002125427 hasConceptScore W2002125427C86803240 @default.
• W2002125427 hasConceptScore W2002125427C8891405 @default.
• W2002125427 hasIssue "5" @default.
• W2002125427 hasLocation W20021254271 @default.

• next